EUVIMEDEUVIMED entdecken
Crossref

Rational Design and Preliminary Evaluation of a Radiopharmaceutical Targeting Fibroblast Activation Proteins [ 68 Ga]Ga/[ 177 Lu]Lu-FAPI-JNU for Tumor Imaging and Therapy

Yihui Luo, Yu Xu, Wenjin Li, Yuqi Hua, Qiaoling Shen, Jialiang Wang, Liping Chen iD, Haitian Fu, Jianguo Lin iD, Chunjing Yu iD

Journal of Medicinal Chemistry · 26.06.2025 · 68 (12) · 12745-12755

DOI: 10.1021/acs.jmedchem.5c00637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 11.06.2025. Verfasst von Yihui Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University, Wuxi 214125, China. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Membrane Proteins, Gelatinases, Drug Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Jiangnan University, Jiangsu Institute of Nuclear Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsMembrane ProteinsGelatinasesDrug DesignSerine EndopeptidasesNeoplasmsAnimalsGallium RadioisotopesHumansMiceTissue DistributionPositron Emission Tomography Computed TomographyLutetiumCell Line, TumorEndopeptidasesFemaleRadioisotopesQuinolinesFibroblast Activation Protein Alpha

Substanzen

RadiopharmaceuticalsGallium RadioisotopesMembrane ProteinsGelatinasesLutetiumSerine EndopeptidasesEndopeptidasesRadioisotopesQuinolinesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University, Wuxi 214125, China.
  • Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu 214122, China.
  • NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu 214063, China.
  • NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, Mianyang, Sichuan 621099, China.

ORCID-Profile: Liping Chen, Jianguo Lin, Chunjing Yu

Förderung

  • Jiangnan University
  • Jiangsu Institute of Nuclear Medicine

Zitieren

APA

Luo, Y., Xu, Y., Li, W., Hua, Y., Shen, Q., Wang, J., Chen, L., Fu, H., Lin, J., & Yu, C. (2025). Rational Design and Preliminary Evaluation of a Radiopharmaceutical Targeting Fibroblast Activation Proteins [ 68 Ga]Ga/[ 177 Lu]Lu-FAPI-JNU for Tumor Imaging and Therapy. Journal of Medicinal Chemistry, 68(12), 12745-12755. https://doi.org/10.1021/acs.jmedchem.5c00637

Vancouver

Luo Y, Xu Y, Li W, Hua Y, Shen Q, Wang J, et al. Rational Design and Preliminary Evaluation of a Radiopharmaceutical Targeting Fibroblast Activation Proteins [ 68 Ga]Ga/[ 177 Lu]Lu-FAPI-JNU for Tumor Imaging and Therapy. Journal of Medicinal Chemistry. 2025;68(12):12745-12755. doi:10.1021/acs.jmedchem.5c00637

BibTeX
@article{Luo2025,
  author = {Luo, Yihui and Xu, Yu and Li, Wenjin and Hua, Yuqi and Shen, Qiaoling and Wang, Jialiang and Chen, Liping and Fu, Haitian and Lin, Jianguo and Yu, Chunjing},
  title = {Rational Design and Preliminary Evaluation of a Radiopharmaceutical Targeting Fibroblast Activation Proteins [ 68 Ga]Ga/[ 177 Lu]Lu-FAPI-JNU for Tumor Imaging and Therapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {12},
  pages = {12745--12755},
  doi = {10.1021/acs.jmedchem.5c00637}
}
Kostenlos starten →